Skip to content

Dossier · DNUT · Dormant

DNUT · Krispy Kreme, Inc. · Stock research

Last analysed ·

Current thesis

Deleveraging-and-refranchising turnaround with a now-dated catalyst: Q2 FY2026 prints 2026-08-06. Net leverage cut to ~5.5x from 6.7x, liquidity >$300M, but revenue still shrinks and ~23-29% of the float is short. The tradeable energy is a squeeze into a binary print, not an accelerating narrative — an $3.35 broken IPO to leave alone until the number lands.

Invalidation trigger

A daily close below $3.00 voids the deleveraging-squeeze case and resumes the broken-IPO downtrend; a weekly close under $2.50 (the 52-week low) confirms fresh de-rating. Secondarily, an August 6 Q2 print that cuts the $140–150M FY Adjusted EBITDA guide or walks back the ≤5.5x year-end leverage target ends the thesis regardless of price.

Thesis status

Open commitment catalyst 3d agoscored if the trigger above fires How this is scored →

Latest analysis and events for DNUT —

As of 2026-07-19, orbyd's latest analysis for Krispy Kreme, Inc. (DNUT): Deleveraging-and-refranchising turnaround with a now-dated catalyst: Q2 FY2026 prints 2026-08-06. Net leverage cut to ~5.5x from 6.7x, liquidity >$300M, but revenue still shrinks and ~23-29% of the float is short. The tradeable energy is a squeeze into a binary print, not an accelerating narrative — an $3.35 broken IPO to leave alone until the number lands.

Invalidation trigger: A daily close below $3.00 voids the deleveraging-squeeze case and resumes the broken-IPO downtrend; a weekly close under $2.50 (the 52-week low) confirms fresh de-rating. Secondarily, an August 6 Q2 print that cuts the $140–150M FY Adjusted EBITDA guide or walks back the ≤5.5x year-end leverage target ends the thesis regardless of price.

Most recent dated event on file: — catalyst 3d ago.

Current Thesis

The growth story was formally ended, not paused: the McDonald's USA Business Relationship Agreement terminated effective July 2, 2025 after the buildout ran roughly $28.9M of unsustainable operating cost, and the path to ~12,000 U.S. doors is gone. What sits in its place is a balance-sheet story. Management has spent four quarters converting company-operated markets into franchise royalties — Japan sold to Unison Capital for roughly $70M, the Western U.S. joint venture stake cut with about $90M from WKS, Insomnia Cookies divested, the dividend suspended, corporate headcount reduced — and every dollar has gone at the debt. Net leverage has moved from 6.7x at year-end 2025 to roughly 5.5x, liquidity is above $300M, bank leverage is under 4x, and the company has tightened its year-end 2026 target to ≤5.5x while guiding to positive cash flow.

That is a credible workout. It is not an accelerating narrative. Revenue still shrank 2.2% YoY to $367M in Q1 FY2026, the FY guide of $1.25–1.35B revenue and $140–150M Adjusted EBITDA leans on international plus an unproven second-half U.S. What has changed since the last read is timing: Krispy Kreme confirmed on July 6 that Q2 FY2026 results land Thursday, August 6, before the open. With ~23–29% of the float short and roughly 10.6 days to cover, that print is the whole trade — and it is binary. Fresh entries into it are a coin flip dressed as a thesis.

Bullish and bearish views on Krispy Kreme, Inc.

The model's bull view on Krispy Kreme, Inc. (DNUT), in brief: Deleveraging is measurable and on schedule: 6.7x net leverage at Q4 2025 → roughly 5.5x now, with the year-end 2026 target tightened to ≤5.5x, bank leverage below 4x, and liquidity above $300M. The bear view: The top line is still contracting. Net revenue fell 2.2% YoY in Q1 FY2026 and the largest growth driver is permanently gone. A deleveraging story with no revenue growth is a bond trade with equity risk attached. Balance-sheet slack is minimal: current ratio 0.36, Debt/Equity… Both cases follow in full.

Bull Case

  • Deleveraging is measurable and on schedule: 6.7x net leverage at Q4 2025 → roughly 5.5x now, with the year-end 2026 target tightened to ≤5.5x, bank leverage below 4x, and liquidity above $300M. Equity in a 5x-levered small cap re-rates violently on each turn taken out.
  • Refranchising cash is real, not projected: about $70M from the Japan sale to Unison Capital and roughly $90M from the WKS Western U.S. transaction, both applied to debt. Management has said one or two further international refranchisings are planned this year — each is a dated, self-generated catalyst that does not require consumer demand to improve.
  • Margin math works even on falling revenue: Q1 FY2026 (reported May 7, 2026) Adjusted EBITDA rose 38% YoY to $33.1M on net revenue of $367M (-2.2%), with capex down 66% YoY. Q4 2025 Adjusted EBITDA had already risen about 21% YoY. Closing unprofitable doors — global points of access down to 15,125 — is landing in the P&L.
  • The February–March re-rating (a ~28% move on the Q4 beat and guide) and the early-July lift on Wall Street Journal turnaround coverage both show how little buying it takes to force covering.
  • Sell-side is asleep: four analysts, a Hold consensus (1 Buy / 2 Hold / 1 Sell), average PT near $4.17 — about 20% above spot. Coverage this thin means one upgrade re-prices the tape.

Bear Case

  • The top line is still contracting. Net revenue fell 2.2% YoY in Q1 FY2026 and the largest growth driver is permanently gone. A deleveraging story with no revenue growth is a bond trade with equity risk attached.
  • Balance-sheet slack is minimal: current ratio 0.36, Debt/Equity 2.08. At ~5.5x against a $140–150M FY EBITDA guide, one soft quarter re-opens the covenant conversation and there is no dividend left to cut as a lever.
  • The H2 U.S. inflection is guided, not evidenced. Management expects U.S. growth as it laps the McDonald's exit — that is arithmetic on an easier comparison, not demonstrated traffic recovery. U.S. per-store demand was weak enough to kill the McDonald's economics in the first place.
  • August 6 is a two-sided event. High short interest amplifies an upside gap and equally amplifies the flush if EBITDA guidance is trimmed or the leverage target slips. Entering a name whose entire thesis resolves in 18 days is a gamble on the number.
  • JAB Holding's majority stake is standing exit supply against a thin float, and any secondary caps the squeeze.
  • Between prints the news flow is promotional — a Girl Scout–inspired dozen on July 7, a July 4 collection, $10-dozen promotions. Nothing on refinancing terms or a replacement distribution partner since Q1.

Setup & Price Structure

A multi-year downtrend from a $17 IPO to roughly $3.35, down about 21.5% over the trailing six months and sitting in the lower half of a $2.50–$5.73 52-week band. Price is below a declining 200-DMA in the low-$4s; the average analyst target of $4.17 sits above spot, which for a broken IPO reads as unrevised estimates rather than upside.

The constructive read is that the $3.00 area has held as a shelf since June, and the early-July move on the Wall Street Journal piece produced a real up-session without follow-through — buyers show up on turnaround headlines and then leave. That is a base attempt, not a breakout. A weekly close back above the $3.75–$4.00 zone with volume would be the first evidence the downtrend is over; nothing on the chart delivers that yet.

For position sizing this behaves as a heavily-shorted small cap where reflexivity, not fundamentals, sets the daily range. It deserves a tight per-name cap, and the honest stance into an August 6 binary is to let the print happen and buy the reaction if the leverage line confirms.

Catalyst Calendar (next 30 days)

  • Undated, this year — one to two additional international refranchising transactions flagged by management. These have historically been announced via 8-K without pre-notice; each carries a debt-paydown headline.
  • No other scheduled events inside the window. Monthly promotional launches are not catalysts and should not be traded as such.

Elapsed catalysts

  • 2026-08-06 — Q2 FY2026 results, confirmed. Release 6:45am ET, conference call 8:00am ET (announced 2026-07-06). The gradeable items: net leverage versus the ≤5.5x year-end target, whether the $140–150M FY Adjusted EBITDA guide holds, and any U.S. same-store commentary supporting the guided H2 inflection. (passed 3d ago)

What Would Change Our Mind

  • A daily close below $3.00 breaks the June shelf and puts the $2.50 52-week low back in play with no operating catalyst until November. That is the level that ends the constructive case.
  • Conversely, an August 6 print showing net leverage at or below 5.5x with the FY EBITDA guide intact and positive U.S. comps, followed by a weekly close above $4.00, converts this from a squeeze setup into an early-innings turnaround worth sizing properly.
  • A cut to the $140–150M Adjusted EBITDA guide, or any walk-back of the ≤5.5x year-end leverage target, ends the thesis at any price — the deleveraging cadence is the only thing being bought here.
  • Announcement of an equity raise or a JAB secondary would invalidate the squeeze mechanics outright by supplying the shorts.
  • A new national distribution partner on economics management publicly defends would reopen a growth narrative and justify a different archetype entirely.

Correlation Notes

  • Trades with small-cap consumer-discretionary turnarounds and levered restaurant workouts rather than with quick-service peers on fundamentals; the beta that matters is to high-yield credit spreads, since the equity is a thin residual on ~5.5x leverage.
  • Sensitive to the Russell 2000 and to rate expectations — a levered small cap re-rates on refinancing cost as much as on doughnut demand.
  • Low correlation to McDonald's since the July 2025 termination removed the operational link; comparing the two is now a capital-allocation exercise, not a paired trade.
  • Within the high-short-interest small-cap cohort, moves cluster: broad squeeze regimes lift DNUT independent of company news, and those moves mean-revert without a fundamental catalyst underneath.

Notes

  • Leverage is the actual scoreboard now: 6.7x at Q4 2025 → ~5.5x currently, guided ≤5.5x year-end 2026, bank leverage <4x, liquidity >$300M. Watch this line on every print ahead of revenue.
  • Refranchising proceeds of record: ~$90M from WKS (Western U.S. JV) and ~$70M from Unison Capital (Japan), both applied to debt paydown; Insomnia Cookies stake divested 2025 (~$127.5M est.).
  • Dividend suspended 2025 to fund debt paydown — no yield support, no income holders to cushion drawdowns.
  • Current ratio 0.36 and Debt/Equity 2.08: liquidity is adequate at the revolver level but the balance sheet has no slack for an operating stumble.
  • Short interest ~21.3–22.4M shares, ~23–29% of float, ~10.6 days to cover — the squeeze mechanics are real but they cut both ways into a print.
  • JAB Holding majority stake = standing secondary/exit supply overhang on a thin float.
  • Sell-side is a Hold consensus (1 Buy / 2 Hold / 1 Sell) with an average PT near $4.17. Coverage is thin enough that a single revision moves the tape.
  • Classified as a retail-squeeze read (tight 1%/name cap): the only tradeable energy is oversold-bounce reflexivity on a heavily-shorted broken IPO, not a fundamental inflection.

Related · shared themes

See also · stocks to watch